Profiel
Leonhard Terp is currently the General Manager at Shire Deutschland GmbH.
Prior to this, he worked as the Managing Director at STALLERGENES GmbH, a Member-Management Board at Shire Orphan Therapies GmbH, and as the General Manager at Shire Deutschland Investments GmbH.
Actieve functies van Leonhard Terp
| Bedrijven | Functie | Begin |
|---|---|---|
Shire Deutschland GmbH
 Shire Deutschland GmbH Pharmaceuticals: MajorHealth Technology Part of Takeda Pharmaceutical Co., Ltd., Shire Deutschland GmbH develops therapies for patients with rare and other specific diseases. The company is based in Berlin, Germany. The CEOs are Uwe Fröhlich, Heidrun Irschik-Hadjieff, Karsten Meisloch. The German company was founded in 1986. | Corporate Officer/Principal | 28-05-2010 |
Eerdere bekende functies van Leonhard Terp
| Bedrijven | Functie | Einde |
|---|---|---|
Shire Orphan Therapies GmbH
 Shire Orphan Therapies GmbH Pharmaceuticals: MajorHealth Technology Shire Orphan Therapies GmbH engages in the development, manufacture, and distribution of chemical and biochemical products, ingredients, as well as pharmaceutical and diagnostic products. The company was founded in 1994 and is headquartered in Berlin, Germany. | Corporate Officer/Principal | 16-01-2013 |
STALLERGENES GmbH
 STALLERGENES GmbH Pharmaceuticals: MajorHealth Technology Stallergenes GmbH prepares and provides pharmaceuticals for the treatment of allergies. The firm's products range from diagnostic to allergen immunotherapy. It develops allergen immunotherapy and allergen supplied with highly innovative and individually tailored solutions. The company is headquartered in Kamp-Lintfort, Germany. | Algemeen Directeur | - |
Shire Deutschland Investments GmbH
 Shire Deutschland Investments GmbH Pharmaceuticals: MajorHealth Technology Part of Takeda Pharmaceutical Co., Ltd., Shire Deutschland Investments GmbH develops and markets pharmaceutical products. The company is based in Berlin, Germany. The CEOs of the German company are Roland Kurney, Heidrun Irschik-Hadjieff. | Corporate Officer/Principal | - |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 4 |
|---|---|
Shire Orphan Therapies GmbH
Shire Orphan Therapies GmbH Pharmaceuticals: MajorHealth Technology Shire Orphan Therapies GmbH engages in the development, manufacture, and distribution of chemical and biochemical products, ingredients, as well as pharmaceutical and diagnostic products. The company was founded in 1994 and is headquartered in Berlin, Germany. | Health Technology |
Shire Deutschland Investments GmbH
Shire Deutschland Investments GmbH Pharmaceuticals: MajorHealth Technology Part of Takeda Pharmaceutical Co., Ltd., Shire Deutschland Investments GmbH develops and markets pharmaceutical products. The company is based in Berlin, Germany. The CEOs of the German company are Roland Kurney, Heidrun Irschik-Hadjieff. | Health Technology |
Shire Deutschland GmbH
Shire Deutschland GmbH Pharmaceuticals: MajorHealth Technology Part of Takeda Pharmaceutical Co., Ltd., Shire Deutschland GmbH develops therapies for patients with rare and other specific diseases. The company is based in Berlin, Germany. The CEOs are Uwe Fröhlich, Heidrun Irschik-Hadjieff, Karsten Meisloch. The German company was founded in 1986. | Health Technology |
STALLERGENES GmbH
STALLERGENES GmbH Pharmaceuticals: MajorHealth Technology Stallergenes GmbH prepares and provides pharmaceuticals for the treatment of allergies. The firm's products range from diagnostic to allergen immunotherapy. It develops allergen immunotherapy and allergen supplied with highly innovative and individually tailored solutions. The company is headquartered in Kamp-Lintfort, Germany. | Health Technology |
